Trial intelligence / Profile preview

PK/PD Interaction of Mefloquine and DHA-PQP in Healthy Volunteers

NCT02324738Phase 4Completed

Sponsor
University of Oxford
Start
Jan 2015
Primary completion
May 2015
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mefloquine, dihydroartemisinin, piperaquine in malaria, sponsored by University of Oxford. Started Jan 2015; status: completed.

02

Drugs

mefloquinedihydroartemisininpiperaquine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02324738.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02324738.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call